Navigation Links
The Monoclonal Antibodies Drug Market for the Treatment of Cancer Will More Than Double to $16.7 Billion By 2016
Date:6/10/2008

Market Will be Driven by Increasing Use of Established Agents That Include Avastin, Erbitux, Rituxan/MabThera, According to a New Report from Decision

Resources

WALTHAM, Mass., June 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the monoclonal antibodies (MAbs) drug market will more than double to $16.7 billion in 2016, driven by the increasing use of currently available therapies that include Roche/Genentech/Chugai's Avastin, Bristol-Myers Squibb/ImClone/Merck KGaA's Erbitux, Genentech/Biogen Idec/Chugai's Rituxan / Roche's MabThera.

The new Pharmacor report entitled Antibody Therapies in Oncology finds that the major driving force behind market growth of the MAbs drug class through 2016 will be the label expansion of currently approved MAbs into other patient populations as well as approvals in new indications in the United States, France, Germany, Italy, Spain, United Kingdom and Japan. In 2006, Avastin held approvals in non-small-cell lung cancer and colorectal cancer -- since that time, of the cancers covered in the report, it has gained approval for breast cancer and renal cell carcinoma and is expected to be approved for prostate cancer and ovarian cancer. Avastin's applicability across multiple tumor types, even if it sees only limited patient share in some indications, is key to its success.

While not as successful as Avastin in terms of revenue generation or its use across as many tumor types, Erbitux generates significant sales in colorectal cancer and squamous cell carcinoma of the head and neck. Also, Erbitux is expected to be approved for the treatment of non-small-cell lung cancer, which will dramatically boost its sales. Lastly, although the use of Rituxan/MabThera in non-Hodgkin's lymphoma has reached saturation in many of the subtypes of the disease, this agent is forecasted to gain approval
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Panacea Pharmaceuticals Announces Selection of PAN-622 - A Fully Human Sequence Monoclonal Antibody Against HAAH - As Its Lead Cancer Therapeutic Product
2. Monoclonal antibody Hb3: A marker for colon cancer progression or as a therapeutic target?
3. Epitomics receives ISO 9001 certification for the production of Rabbit Monoclonal Antibodies.
4. Scripps Research scientists shed new light on how antibodies fight HIV
5. Micromets BiTE(R) Antibodies Reveal Unique Mode of Action
6. Prenatal exposure to maternal antibodies linked to autistic behaviors in offspring
7. Autoantibodies and neuropsychiatric events in lupus
8. Vegan diet promotes atheroprotective antibodies in patients with rheumatoid arthritis
9. Anti-HAV antibodies in beta-thalassemia
10. Researchers Develop Quick Way to Create Human Antibodies
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... TX (PRWEB) January 22, 2015 The Incredible ... Bodybuilder Ben Pakulski to increase lean muscle by up to ... has caught the attention of HealthyandFitZone.com’s Stan Stevenson, prompting an ... that it is a step-by-step, scientific diet formula that allows ...
(Date:1/22/2015)... New York (PRWEB) January 22, 2015 The ... ) in the U.S. District Court, Southern District of West ... Bard, Inc. in that proceeding’s first bellwether trial. In an ... for a new trial after finding that C.R. Bard had ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining ... policy . , Auto insurance quotes help many drivers ... longer necessary to call an agent or visit an agency ... a single website: http://autocarinsurancebest.com/ . , Every business who ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... Boulder, Colorado (PRWEB) January 22, 2015 Four years ... is Queen – which coincided with the marriage of Avasa & ... album, THE ROAD, which is scheduled for release through White Swan ... heartfelt message that there is a sacred path available to all ...
Breaking Medicine News(10 mins):Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4
... system network decays with aging , , THURSDAY, Jan. 15 ... regions of the brain may have more of a ... a new study says. , By comparing ... adults, Massachusetts Institute of Technology (MIT) neuroscientists discovered a ...
... to Fund Lung Cancer ResearchBOSTON, Jan. 15 ... Fargo (D-3rd Middlesex), the Senate Chair of the ... introducing comprehensive legislation that creates a trust fund ... )"Now is the time for positive change for ...
... 15 Pennsylvania Insurance Commissioner Joel Ario ... Jan. 14 vote by the U.S. House of Representatives ... Program): "I am very pleased that SCHIP reauthorization ... been approved by the U.S. House. To ensure the ...
... On Tuesday, February 3, 2009, legendary folk icon, ... Beyond Beauty Gala to benefit The James E. Marshall ... awareness for Obsessive-Compulsive Disorder (OCD). Hosted by television ... be held at The Union League Club in New ...
... Luther King Day in Washington ... at the Martin Luther King Library CHICAGO, Jan. 15 ... on Martin Luther King Jr. Day, Monday, January 19th, at 12:00pm, ... King III, David Arquette, and musical performances by Josh Groban and ...
... division of Harvard Medical School, announces the launch of its redesigned ... search of trusted health care information. , ... Boston, ... division of Harvard Medical School, announces the launch of its redesigned ...
Cached Medicine News:Health News:Lung Cancer Alliance Hails Massachusetts State Senator for Taking Lead on Lung Cancer 2Health News:Legendary Folk Icon, Judy Collins, to Perform at The Fifth Annual James E. Marshall OCD Foundation Beyond Beauty Gala 2Health News:Legendary Folk Icon, Judy Collins, to Perform at The Fifth Annual James E. Marshall OCD Foundation Beyond Beauty Gala 3Health News:Feeding America, Martin Luther King III, David Arquette, Josh Groban and Herbie Hancock Join Forces to Combat Hunger in America on Presidential Inaugural Committee National Day of Service 2Health News:Feeding America, Martin Luther King III, David Arquette, Josh Groban and Herbie Hancock Join Forces to Combat Hunger in America on Presidential Inaugural Committee National Day of Service 3Health News:Harvard Health Publications Launches New Consumer Website 2Health News:Harvard Health Publications Launches New Consumer Website 3
(Date:1/23/2015)... Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT), announced ... trial of Lixte,s lead compound, LB‑100, is being conducted, has ... John S. Kovach , M.D., the founder and President of ... completed at a single site. Accrual of patients, however, was ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
(Date:1/23/2015)... BOSTON , January 23, 2015 Heptares ... is delighted to announce that the Malcolm Campbell ... Congreve (Vice President of Chemistry), Fiona Marshall ... (Chief Executive Officer and co-founder) for the seminal contributions to ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... Oct. 13, 2011 The American Association for Homecare ... to include any additional budgetary spending cuts that will ... in its recommendations to Congress. Over the years, ... Americans, while also producing cost-savings in the health care ...
... NEW YORK, Oct. 13, 2011 Techstreet, ... providing corporate subscriptions to the International Society for Pharmaceutical ... publications it currently offers. The online subscription service is ... it provides unlimited access to the latest ISPE Documents ...
Cached Medicine Technology:American Association for Homecare Calls on Joint Deficit Committee in Congress to Preserve Homecare Access for Millions of Americans 2Techstreet and the ISPE Extend Partnership to Expedite Drug Research with Subscription Offering for Life Science Engineers 2
High-quality, epoxy-coated, stackable steel cabinets for the storage of microscope slides, slide filing wallets, processing cassettes, tissue blocks, transparencies and A5 index cards....
Allows for the organized storage of blocks that have been embedded using: Tissue Cassettes, Biopsy Cassettes, Mesh Cassettes, Mega Cassettes, Processing/Embedding Cassettes and Embedding Rings....
Individually, self-contained, stackable drawers....
Shandon Stackable Slide Storage Cabinet...
Medicine Products: